Trump's Autism Claim About Acetaminophen in Pregnancy Debunked by Science

In September 2020, former US President Donald Trump suggested that taking acetaminophen (paracetamol) during pregnancy could raise the risk of autism in children. The claim sparked immediate backlash from researchers, medical professionals, and advocacy groups concerned about its accuracy and implications.

Trump's statement contradicted years of scientific research. Large-scale studies, including a 2021 analysis in JAMA Pediatrics (Wood et al.), examined over 250,000 children across 16 cohorts. The findings showed no reliable evidence linking prenatal acetaminophen use to autism, instead pointing to other factors like genetic predisposition or the underlying reasons for taking the medication.

Epidemiologist Brian Lee, who led one of the most comprehensive peer-reviewed studies on the topic, reinforced these conclusions. His work, along with a 2024 systematic review by the European Medicines Agency, found no consistent causal connection. Many experts argued that Trump's claim overlooked the well-documented dangers of untreated fever during pregnancy, which can harm both mother and child.

The remarks also drew criticism from autistic individuals and their families. They objected to the framing of autism as a negative outcome rather than a natural variation in human development. Advocacy groups stressed the importance of responsible language when discussing neurodiversity.

Years of rigorous research have found no clear link between acetaminophen use in pregnancy and autism. Medical professionals continue to recommend the drug for managing fever and pain when necessary. The controversy, however, highlighted ongoing debates about how autism is discussed in public health conversations.